杠杆&ETF资金分化：流动性&交易拥挤度&投资者温度计周报-20251027

Group 1: Liquidity and Fund Flow - The supply side of funds continues to shrink, with public fund issuance maintaining historical median levels, while leveraged funds have seen a net inflow returning to high levels[3] - Equity financing has expanded to a historical high, reaching a new peak since July this year, with southbound funds accumulating a net inflow of over 570 billion CNY in the past five months[3][10] - The net inflow of margin financing reached approximately 267.3 billion CNY, marking a significant turnaround from a previous outflow of 140 billion CNY, placing it in the 83rd percentile over the past three years[17] Group 2: Trading Congestion and Market Sentiment - The trading heat for insurance, central enterprises, and banks has increased, with insurance rising by 32 percentage points to 48%, central enterprises by 26 percentage points to 49%, and banks by 25 percentage points to 56%[3][57] - Conversely, the trading heat for electronics, home appliances, and media has decreased, with electronics down 23 percentage points to 53%, home appliances down 17 percentage points to 59%, and media down 14 percentage points to 13%[3][70] - Retail investor net inflow in the A-share market was 682.6 billion CNY, a decrease of 1,225.1 billion CNY from the previous value, placing it in the 23.1 percentile over the past five years[3] Group 3: ETF and Repurchase Trends - Stock-type ETFs experienced a net outflow of 299.2 billion CNY, a significant drop from a previous net inflow of 260.8 billion CNY, placing the sentiment at a low point in the past three years[24] - The amount of repurchase by listed companies decreased to 13.1 billion CNY from 16.0 billion CNY, which is in the 36th percentile over the past three years[27] Group 4: Sector Performance - The net inflow in the electronics sector was 148.6 billion CNY, while the automotive sector saw a net outflow of 13.5 billion CNY[23] - The net inflow in the communication sector was 46.2 billion CNY, with a net outflow in the pharmaceutical sector of 3.0 billion CNY[23]